Juengel, E., Engler, J., Natsheh, I., Jones, J., Mickuckyte, A., Hudak, L., . . . Blaheta, R. A. (2009). Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells. BioMed Central.

Juengel, Eva, Johanna Engler, Iyad Natsheh, Jon Jones, Ausra Mickuckyte, Lukasz Hudak, Dietger Jonas, i Roman A. Blaheta. Combining the Receptor Tyrosine Kinase Inhibitor AEE788 and the Mammalian Target of Rapamycin (mTOR) Inhibitor RAD001 Strongly Inhibits Adhesion and Growth of Renal Cell Carcinoma Cells. BioMed Central, 2009.

Juengel, Eva, et al. Combining the Receptor Tyrosine Kinase Inhibitor AEE788 and the Mammalian Target of Rapamycin (mTOR) Inhibitor RAD001 Strongly Inhibits Adhesion and Growth of Renal Cell Carcinoma Cells. BioMed Central, 2009.